Literature DB >> 17114914

Development of acromegaly in a patient with anorexia nervosa: pathogenetic and diagnostic implications.

E de Menis1, M Gola, A Giustina.   

Abstract

Anorexia nervosa (AN) is a psychosomatic disorder characterized by an alteration in body image, resulting in eating abnormalities that lead to malnutrition associated with secondary endocrinological disturbances. AN is associated with high levels of GH and low levels of IGF-I, suggestive of a nutritionally acquired lack of GH action or GH resistance and of an unbalanced hypothalamic GH neuroregulation with GHRH prevalence on SS tone. In this clinical report, we describe the development of acromegaly in a patient affected by AN and we discuss pathogenetic and diagnostic implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114914     DOI: 10.1007/BF03347377

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

Authors:  A Giustina; J D Veldhuis
Journal:  Endocr Rev       Date:  1998-12       Impact factor: 19.871

Review 2.  Genetic basis of endocrine disease: pituitary tumor pathogenesis.

Authors:  I Shimon; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

3.  Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.

Authors:  N R Biermasz; H van Dulken; F Roelfsema
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

4.  Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.

Authors:  Nienke R Biermasz; Jan W A Smit; Hans van Dulken; Ferdinand Roelfsema
Journal:  Clin Endocrinol (Oxf)       Date:  2002-03       Impact factor: 3.478

5.  Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa.

Authors:  L De Marinis; A Mancini; D Valle; A Bianchi; R Gentilella; D Milardi; C Mascadri; A Giustina
Journal:  Metabolism       Date:  2000-02       Impact factor: 8.694

Review 6.  Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa.

Authors:  Massimo Scacchi; Angela Ida Pincelli; Francesco Cavagnini
Journal:  Front Neuroendocrinol       Date:  2003-07       Impact factor: 8.606

7.  Physiological role of galanin in the regulation of anterior pituitary function in humans.

Authors:  A Giustina; M Licini; M Schettino; M Doga; G Pizzocolo; A Negro-Vilar
Journal:  Am J Physiol       Date:  1994-01

8.  Galanin receptors from human pituitary tumors assayed with human galanin as ligand.

Authors:  A L Hulting; T Land; M Berthold; U Langel; T Hökfelt; T Bartfai
Journal:  Brain Res       Date:  1993-10-15       Impact factor: 3.252

9.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa.

Authors:  E Ghigo; E Arvat; L Gianotti; M Nicolosi; M R Valetto; S Avagnina; D Bellitti; M Rolla; E E Müller; F Camanni
Journal:  Biol Psychiatry       Date:  1994-11-15       Impact factor: 13.382

View more
  1 in total

Review 1.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.